师资力量

 
 
教师信息 首页 >> 师资力量
崔恒宓
发布日期:2016-03-17浏览次数:字号:[ ]
  

  崔恒宓

  (Hengmi Cui, PhD

  博导,特聘教授

  扬州大学表观遗传学及表观基因组学研究所

  扬州大学动物科学和技术学院

  E-mailhmcui@yzu.edu.cn

 

简介:

  于1997年获瑞典Uppsala大学博士学位,其后在美国约翰霍普金斯大学先后作博士后、讲师和副教授,美国国家卫生研究院 (NIH)资深科学家。曾获得约翰霍普金斯大学W. Barry Wood优秀博士后奖和优秀Jr. Faculty基础研究奖。担任《BMC Medical Genetics》等多个SCI杂志副主编或编委。曾担任美国NIH研究项目评委、意大利和奥地利国家科学基金特邀评委。在SCI杂志发表论文60多篇,包括《Nature》、《Science》等世界一流杂志。文献引用超过8000次。

  2013年被扬州大学作为重点引进人才,聘为特聘教授、扬州大学表观遗传学及表观基因组学研究所所长。同年,入选江苏省高层次创新创业人才引进人才,担任江苏省双创人才联合会常务理事兼生物医学专委会副主任。回国后,积极开展国际前沿研究,特别是在内源性反转录病毒这个未开垦领域,目前已取得具有重大科学意义的突破性进展,还发现了癌基因致癌新表观遗传机制和肿瘤药物去甲基化试剂AZA抗肿瘤的新机制。先后主持“973”课题1项、国家自然科学基金重大研究计划项目1项、国家自然科学基金面上项目2项和参加国家重点研发计划项目1项。发表SCI论文16篇(其中一区2篇,二区2篇),中文核心期刊12篇,申请国家发明专利12项。创立了扬州大学表观遗传学及表观基因组学研究所,主办国际肿瘤表观遗传学会议,为国内表观遗传学研究做出了积极贡献。开设研究生《表观遗传学》课程和《分子生物学》课程。主持扬州大学表观遗传学学科建设并带出一支创新团队。四年里,已培养和正在培养博士后、硕博士生25名。

 

1 学习经历:

1997/08-2000/06

美国约翰霍普金斯(Johns Hopkins)大学医学院

博士后,导师:Professor. Andrew  Feinberg

1993/09-1997/05

瑞典乌普撒拉(Uppsala)大学发育和分子遗传系

博士, 导师:ProfessorRolf  Ohlsson

1982/02-1985/01

扬州大学(原江苏农学院)  畜牧兽医系

硕士,导师:张照教授

1978/03-1982/01

南京农业大学(原南京农学院)畜牧兽医系

学士

2 工作经历:

2013/01-至今

扬州大学表观遗传学及表观基因组研究所所长

特聘教授

2011/11-2013/01

美国国家卫生研究院癌症研究所(NCI/NIH

资深科学家

2003/07-2010/06

美国约翰霍普金斯大学医学院

副教授

2000/06-2003/06

美国约翰霍普金斯大学医学院

讲师(Instructor

1992/11-1993/10

英国剑桥大学 Babraham 研究所

访问学者

1992/01-1992/10

扬州大学动物科学与技术学院

副教授

1989/04-1992/01

扬州大学动物科学与技术学院

讲师

1986/02-1989/03

扬州大学动物科学与技术学院

助教

1985/02-1986/01

中国科学院上海细胞生物学研究所

进修

3 研究方向:

1.人类肿瘤表观遗传学机制;

2.表观遗传学与动物育种;

3.非编码RNA的作用和功能;

4.内源性反转录病毒的作用和功能等。

4 学术任职:

项目评审

2008          Austrian Science Fund, FWF Der Wissenschaftsfonds

2011          The grants of the Italian Ministry of Health (MOH)

2009-2011     NIH/NCI, SBIR program

2016          国家自然科学基金评委

专业会员

2002-         美国人类遗传学协会会员(Member, The American Society of Human Genetics

2002-         美国癌症协会会员(Member, American Association for Cancer Research

2004-         美国科学促进会会员(Member, American Association for the Advancement of Sciene

2016-         江苏省双创人才江苏省双创人才联合会常务理事,生物医学专委会副主任。

杂志编委:

2011-present       Open Medicine Journal (Associate Editor)

2009-present       BMC Medical Genetics (Associate Editor),

2010-present       World Journal of Clinical Oncology (Editorial Board Member)

2011-present       World Journal of Experimental Medicine (Editorial Board Member)

2011-present       TheScientificWorldJournal (TSWJ) (Editorial Board Member)

5 荣誉奖励:

1990

Excellent teaching award, Yangzhou University, China

1993-1994

Wenner-Gren Foundation Scholarship, Karolinska Institute, Sweden

1994-1996

Von Hofsten Foundation Award, Uppsala University, Sweden

2000

W. Barry Wood Jr. Award for postdoctoral fellow, Johns Hopkins University School of Medicine

2004-2006

Finalist of Jr. Faculty Basic Science Research award, Department of Medicine, Johns Hopkins University School of Medicine.

2008

 

Winner of Jr. Faculty Basic Science Research award, Department of Medicine, Johns Hopkins University School of Medicine.

2013

江苏省高层次双创人才

 

 6 科研情况:

研究项目

  1.环境因素及表观遗传学在肾小球损伤中的机制 (2012CB517605)国家973项目课题,2012-2016,课题主持人

  2.结直肠癌 IGF2 基因内含子miR-483 的致癌机制研究(81171965),国家自然科学基金面上项目, 2012-2015,主持人

  3.反义RNA 及抑癌基因表观遗传学沉默分子机制研究(81372237),国家自然科学基金面上项目, 2014-2017,主持人

  4.源于鸡内源性白血病病毒的反义长非编码RNA的功能及表观遗传学调控机制(91540117)自然科学基金重大研究计划,2016-2018, 主持人

  5.消化道癌的多维分子分型及诊断分子标志物研究(2016YFC1303604)国家重点研发计划,2017-2021,研究骨干

  6.反义RNA表观遗传沉默导致癌相关基因激活的致癌新机制研究(81773013),国家自然科学基金面上项目,2018-2021,主持人

7 发表论文

  英文文章

  1.Jin R, and Cui H, Reproductive characteristics of Taihu pigs, Pig News & Information (Britain), 3:99-102, 1992.

  2.Ekstrom TJ, Cui H, Li X, and Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development, Development, 1995;121:309-316. IP:85

  3.Ekstrom TJ, Cui H, Nystrom A, Rutanen EM, and Ohlsson R. Monoallelic expression of IGF2 at the human fetal/maternal boundary, Mol Reprod and Develop, 1995;41:177-183.

  4.Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, and Ekstrom TJ. Expression, promoter usage and parental imprinting status of Igf2 in human hepatoblastoma: uncoupling of IGF2 H19 imprinting. Oncogene. 1995;11:221-229.

  5.Ohlsson R, Ekstrom T, Franklin G, Pfeifer-Ohlsson S, Cui H, Miller S, Fisher R, and Walsh C. Plasticity of Imprinting. In Genomic imprinting: Causes and Consequences. (R. Ohlsson, K. Hall and M. Ritzen, Eds.), Cambridge University Press. 1995;pp. 182-194.

  6.Cui H#, Xu WX, Powell D, and Newman B. Cloning and sequencing of a pig cdc25 tyrosine phosphatase cDNA, Journal of Animal Science, 1995;73:630.

  7.Cui H#. andOhlsson R., An improved protocol for purification of 35S-labelled oligonucleotide DNA probes for in situ hybridization applications. Trends in Genetics, 1996;12:506-507.

  8.Li X, Cui H, Sandstedt B, Nordlinder H, Larsson E, and Ekstrom TJ. Expression levels of the Igf2 in the human liver: developmental relationships of the four promoters, Journal of Endocrinology, 1996;149:117-124.

  9.Adam GI, Cui H, Miller SJ, Flam F, and Ohlsson R, Allelic specific in situ hybridization analysis: a novel technique which resolve differential allelic usage of H19 within the same cell lineage during human placental development. Development, 1996;122:839-847.

  10.Cui H#, Hedborg F, He L, Nordenskjold A, Sandstedt B, Pfeifer-Ohlsson S, and Ohlsson R. Inactivation of H19, an imprinted and putative repressor gene, is a preneoplastic event during Wilms' tumorigenesis,Cancer Research, 1997; 57:4469-473.

  11.Cui H#,Horon IL, Ohlsson R, Hamilton SR, and Feinberg AP.  Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.  Nature Medicine, 1998; 4:1276-1280.

  12.Li YM, Franklin G, Cui H, Svensson K, He XB, Adam G, Ohlsson R, and Pfeifer S. The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans. Journal of Biological Chemistry, 1998;273:28247-28252.

  13.Randhawa GS#, Cui H#, Barletta JA, Strichman-Almashanu LZ, Talpaz M, Kantarjian H, Deisseroth AB, Champlin RC, and Feinberg AP.  Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood, 1998;91:3144-3147.(*Co-first author)

  14.He L, Cui H, Walsh C, Mattsson R, Lin W, Anneren G, Pfeifer-Ohlsson S, and Ohlsson R Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells. Oncogene, 1998;16:113-119.

  15.Ohlsson R, Cui H, He L, Pfeifer S, Malmikumpu H, Jiang S, Feinberg AP, and Hedborg F.  Mosaic allelic IGF2 expression patterns reveal a link between Wilms’ tumorigenesis and epigenetic heterogeneity. Cancer Research, 1999;59:3889-3892.

  16.Ohlsson R, Flam F, Fisher R, Miller S, Cui H, Pfeifer S & Adam GI. Random monoallelic expression of the imprinted IGF2 and H19 genes in the absence of discriminative parental marks. Development in Genes Evolution, 1999;209:113-119.

  17.Uejima, H, Lee, MP, Cui, H, and Feinberg, AP.  Hot stop PCR: A simple and general assay for linear quantitation of allele ratios. Nature Genetics, 2000;25:375-376.

  18.Ohlsson, R., Svensson, K., Cui, H., Malmikumpu, H. and Adam, G. Allele-specific in situ hybridisation (ASISH) Methods in Molecular Biology: Genomic imprinting (A. Ward, editor; Humana Press Inc., Totowa, New Jersey, USA). 2001; pp 153-169.

  19.Cui H#, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, and Feinberg AP. LOI of IGF2 in Wilms’ tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Research, 2001; 61:4947-4950.

  20.Rhee I, Bachman KE, Park BH, Jair K-W, R-W C, Yen, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, and Vogelstein B. DNMT1 and DNMT3B cooperate to silence genes in human cancer cells, Nature, 2002,;416:552-556.

  21.Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, Feinberg AP, Ohlsson R, Morse HC 3rd, Lobanenkov VV., BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.Proc Natl AcadSci USA, 2002;99:6806-6811.

  22.Onyango, P, Jiang, S, Uejima, H, Shamblott, MJ, Gearhart, JD, Cui, H, and Feinberg, AP. Imprinting in human embryonic germ cells without germline transmission, Proc Natl AcadSci U S A, 2002;99:10599-604.

  23.Feinberg, A.P., Cui, H. and Ohlsson, R. DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms.Seminars in Cancer Biology, 2002;12:389.

  24.Cui H#, Onyango P., Brandenburg S, Wu Y., Hsieh C-L and Feinberg AP. Loss of imprinting in human colorectal cancers linked to hypomethylation of H19 and IGF2, Cancer Research, 2002; 62:6442-6446.

  25.Cruz-Correa M, Cui H, Powe N, Giardiello FM, Feinberg A., Loss of imprinting of the IGF2 gene is a diffuse colorectal molecular abnormality which may predict colorectal cancer risk, Gastroenterology, 2002; 122 : 297 Suppl.

  26.Cruz-Carrea M, Cui H, Giardiello FM, Palmer A, Hylind L, Feinberg A, Loss of imprinting of IGF2 is an epigenetic marker independently associated with colorectal cancer and not related to tobacco or alcohol consumption, Gastroenterology, 2003;124: A550-A550 Suppl.

  27.Cui H#., Cruz-Correa M., Giardiello F. M., Hutcheon D. F., Kafonek D. R., Brandenburg S., Wu Y., He X., Powe N. R,. & Feinberg A. P., Loss of IGF2 Imprinting: A Potental Marker of Colorectal Cancer Risk. Science, 2003;299:1753-1755.

  28.Cruz-Correa M., Cui H., Giardiello F. M., Powe N. R, Hylind L., Robinson A., Hutcheon D. F., Kafonek D. R., Brandenburg S., Wu Y., He X.,. & Feinberg A. P. Loss of imprinting of IGF2 gene, a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology, 2004;126: 964-70.

  29.Cruz-Correa M, Zhao RH, Hylind L, Cuffari C, Cui H, Feinberg A, Giardiello F. Genomic imprinting of the insulin growth factor-2 gene is a constant epigenetic abnormality associated with colorectal cancer risk. Gastroenterology, 2004;126:A2-A3 Suppl.

  30.Hu Y, Zheng M, Xu Z, Wang X & Cui H*. Quantitative real time PCR technique for rapid prenatal diagnosis of down syndrome. Prenatal Diagnosis, 2004;24:704-707.

  31.Cui H#, Gius H#, Bradbury CM, Cook J, Smart DK, Zhao S, Young L, Brandenburg SA, Hu Y, Munson PJ, Chuang EY, Mitchell JB, and Feinberg AP, Distinct Effects on Gene Expression of Chemical and Genetic Manipulation of the Cancer Epigenome Revealed by a Multimodality Approach. Cancer Cell, 2004;6:361-371. * Co-first authors.

  32.Bjornsson HT, Cui H, Gius D, Fallin MD, Feinberg AP., The new field of epigenomics: implications for cancer and other common disease research, Cold Spring HarbSymp Quant Biol. 2004;69:447-56.

  33.Yang R, Murillo FM, Cui H, Blosser R, Uematsu S, Takeda K, Akira S, Viscidi RP, Roden RB., Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88, J Virol. 2004 78:11152-60. IP:66

  34.Hu YL, Chen X, Chen LL, Xu ZF, Wang XR, Cui H*. (2006) Comparative genomic hybridization analysis of spontaneous abortion, International Journal of Gynecology & Obstetrics, 2006; 92:52-57.

  35.Cui H*, Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer(review), Disease Markers, 2007;23:105-112.

  36.Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, Shankavaram UT, Ziegler MS, Stewart C, Kouros-Mehr H, Cui H, Dolginow D, Scudiero DA, Pommier YG, Munroe DJ, Feinberg AP, Weinstein JN, Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells, Mol Cancer Ther., 2007;6:391-403.

  37.Dai Y, Wang Z , Li J, Gu X, Zheng M, Zhou J, Ye X, Yao J, Hu Y and Cui H*, Imprinting status of IGF2 in cord blood cells of Han Chinese newborns, Int. J. Mol. Sci.2007; 8: 273-283.

  38.Yu W, Gius G, Onyango P, Karp J, Feinberg AP and Cui H*, Epigenetic silencing of tumor suppressor gene p15 by its antisense RNA, Nature, 2008;451:202-206.

  39.Sun L, Huang L, Nguyen P, Bisht KS, Bar-Sela G, Ho AS, Bradbury CM, Yu W, Cui H, Lee S, Trepel JB, Feinberg AP &Gius D. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation, Cancer Res. 2008;68:2726-2735.

  40.Cui H#, Nguyen P, Bisht K, Sun L, Patel K, Lee R, Kogoh H, Oshimura M, Oshimura M, Feinberg AP, Gius D. CTCFL/BORIS is a methylation independent DNA-binding protein that preferentially binds to the paternal H19 DMR, Cancer Res, 2008;68:5546-51.

  41.Bjornsson HT,  Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekström TJ, Harris TB, Launer LJ, Eiriksdottir G, Leppert MF, Sapienza C, Gudnason V, Feinberg AP. Intra-individual Change Over Time in DNA Methylation With Familial Clustering, JAMA. 2008;299:2877-2883.

  42.Nguyen P, Bar-Sela G, Sun L, Bisht KS, Cui H, Kohn E, Feinberg AP, Gius D. BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression, Mol Cell Biol.2008;28:6720-6729.

  43.Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet., 2009;41:178-186.

  44.Cruz-Correa M, Zhao R, Oviedo M, Bernabe RD, Lacourt M, Cardona A, Lopez-Enriquez R, Wexner S, Cuffari C, Hylind L, Platz E, Cui H, Feinberg AP, Giardiello FM. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. Epigenetics. 2009;27;4(2).

  45.Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, Casson AG. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues. Carcinogenesis. 2009;30(12):2117-22.

  46.Cui I & Cui H*, Antisense RNA and epigenetic regulation, Epigenomics, 2010; 2(1):139-150.

  47.Zhang Y, Diao Z, Su L, Sun H, Li R,  Hu Y, Cui H*,miRNA-155 contributes to preeclampsia by downregulating CYR61, Am J Obstet Gynecol., 2010;202(5):466.e1-7.

  48.Rodriguez BA, Weng YI, Liu TM, Zuo T, Hsu PY, Lin CH, Cheng AL, Cui H, Yan PS, Huang TH, Estrogen-Mediated Epigenetic Repression of the Imprinted Gene Cyclin Dependent Kinase Inhibitor 1C in Breast Cancer Cells. Carcinogenesis. 2011, 32(6):812-21.

  49.Cui H#*, Antisesne RNAs and modulation of tumor suppressor genes, Long Non-coding RNAs: Regulation of Gene Expression and Drivers of Natural Selection, Horizon Scientific Press2011153-166.

回国后

  50.Zhao X, Tang Z, Zhang H, Atianjoh FE, Zhao JY, Liang L, Wang W, Guan X, Kao SC, Tiwari V, Gao YJ, Hoffman PN, Cui H, Li M, Dong X, Tao YXA long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci. 2013, 16(8):1024-31.

  51.Jeong Y, Du R, Zhu X, Yin S, Wang J, Cui H, Cao W, and Charles J. Lowenstein. Histone Deacetylase isoforms regulate innate immune response by deacetylating mitogen-activated protein kinase phosphatase. J Leukocyte Biol2014, 95(4):651-9

  52.Zhang Z, ElSayed AK, Shi Q, Zhang Y, Zuo Q, Li D, Lian C, Tang B, Xiao T, Xu Q, Chang G, Chen G, Zhang L, Wang K, Wang Y, Jin K, Wang Y, Song J, Cui H, Li B, Crucial Genes and Pathways in Chicken Germ Stem Cells Differentiation.J Biol Chem. 2015, 290(21): 13605-21.

  53.Yusuf MS, Hassan MA, Elnabtiti AS, Cui H*, A single dose of ginger powder, supported with organic acid or probiotic, maximizes the laying, egg quality hatchability and immune performances of laying japanese quails, International Journal of Recent Scientific Research, 2015,6(10), 6707-6711.

  54.Geng T , Xia L, Li F, Xia J, Zhang Y, Wang Q, Yang B, Montgomery S, Cui H, Daoqing Gong, The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver, Biochemical and Biophysical Research Communications, 2015, 465, 83-87.

  55.Gao B, Shen D, Xue S, Chen C, Cui H* and Song C*The contribution of transposable elements to size variations between four teleost genomes. Mobile DNA, 2016, Feb 9;7:4. doi: 10.1186/s13100-016-0059-7.

  56.Hu X, Zhu W, Chen S, Liu Y, Sun Z, Geng T, Wang X, Gao B, Song C, Qin A and Cui H*, Expression of the env gene from the avian endogenous retrovirus ALVE and regulation by miR-155, Archives of Virology, 2016, ;161(6):1623-32.

  57.Zhao J, Yao J, Li F, Yang Z, Sun Z, Qu L, Wang K, Su Y, Geng T, Cui H*, Identification of candidate genes for chicken early- and late-feathering, Poultry Science, 2016, 95(7):1498-503.

  58.Hu X, Zhu W, Chen S, Liu Y, Sun Z, Geng T, Wang X, Gao B, Song C, Qin A and Cui H*, Expression patterns of endogenous avian retroviruses, ALVE1, and its response to infection of exogenous avian tumor viruses, Archives of Virology, 2016, 162(1):89-101. 

  59.Cui H#*, Liu Y, Jiang J, Liu Y, Yang Z, Wu S, Cao W, I H. Cui, Yu C, IGF2-derived miR-483 mediated oncofunction through targeting DLC1 and was a potential noninvasive biomarker of colorectal cancer, Oncotarget, 2016, 7(30):48456-48466.

  60.Geng T, Zhao X, Xia L, Liu L, Li F, Yang B, Wang Q, Montgomery S, Cui H, Gong D. Supplementing dietary sugar promotes endoplasmic reticulum stress-independent insulin resistance and fatty liver in goose.BiochemBiophys Res Commun. 2016 May 28. pii: S0006-291X(16)30899-3. doi: 10.1016/j.bbrc.2016.05.149.

  61.Chen S, Hu X, Zhu W, Jia C, Han X, Sun Z, Yang Z, Geng T, Cui H*Regulation of development genes reactivated via 5-Aza-2’-deoxycytidine by canonical Wnt signaling in chicken embryo fibroblasts, Poultry Science, 2016, doi: 10.3382/ps/pew378.[Epub ahead of print]

  62.Yusuf MS, Hassan MA, Abdel-Daim MM, Elnabtiti AS, Ahmed AM, Moawed SA, El-Sayed AK, Cui H* (2016) Value added by Spirulina platensis in two different diets on growth performance, gut microbiota, and meat quality of Japanese quails, Veterinary World, 9(11): 1287-1293.

  63.Mohamed S. Yusuf, Mohammed T. Ibrahim, Hayam M. Sam, Manal M.A. Mahmoud and Hengmi Cui*, Yeast, Lactose, and Organic Acids Mixture Improved Zoological Growth and Immune Status of Japanese quails, Nature and Science 2016, 14(4): 1-13.

  64.Liu Y, Han X, Yuan J, Geng T, Chen S, Hu X, Cui IH, Cui H*. Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes.J Biol Chem. 2017, 292(14):5624-5633.

  65.Gao B, Wang S, Wang Y, Shen D, Xue S, Chen C, Cui H, Song C. Low diversity, activity, and density of transposable elements in five avian genomes. FunctIntegr Genomics. 2017 Feb 11. doi: 10.1007/s10142-017-0545-0. [Epub ahead of print]

  66.Gao D, Herman JG, Cui H, Jen J, Fuks F, Brock MV, Ushijima T, Croce C, Akiyama Y, Guo M. Meeting Report of the Fifth International Cancer Epigenetics Conference in Beijing, China,Epigenomics, 2017 May 22. doi: 10.2217/epi-2017-0030. [Epub ahead of print]

  67.Li H, Lv B, Kong L, Xia J, Zhu M, Hu L, Zhen D, Wu Y, Jia X, Zhu S, Cui H*. Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway.Int J Mol Med. 2017 Aug 3. doi: 10.3892/ijmm.2017.3089. [Epub ahead of print]

中文文章

  1.崔恒宓#,生物新技术与猪品种改良,《当代畜牧》 1990 04:1-2

  2.李碧春,经荣斌,龚允陈,林大光,崔恒宓,毛九德,李松,二花脸猪早期胚胎发育的初步研究,《养猪》 1993 01:29-33

  3.崔恒宓#,经荣斌,金韶华,毛九德,储新生,唐士余,龙广凤,复合免疫增强剂对仔猪增重及血像和某些免疫学指标的影响,《养猪》 1993 01:5-6

  4.经荣斌,崔恒宓,章世元,毛九德,刘铁铮,葛云山,徐晓波,储新生,唐士余,龙广风,商品肉猪快速生长饲养技术试验报告,《养猪》 1992 04:18-19

  5.崔恒宓#,葛翔,詹彩娇,丁广新,新配合料与50%“311”料饲喂乳猪对比试验,《畜牧与兽医》 1989 06:247

  6.崔恒宓*,正确对待猪的微量元素添加剂,《养猪》 1989 02:10

  7.崔恒宓*,猪胚胎死亡原因,《上海畜牧兽医通讯》 1990 05:40-41

  8.崔恒宓*,猪胚胎移植技术研究进展,《国外畜牧科技》 1987 05期:18-20

  9.经荣斌,崔恒宓,太湖猪若干经济性状的研究及利用,《养猪》 1991 03期:26-30

  10.崔恒宓#,姜曲海母猪性发育过程中血浆雌二醇和孕酮含量变化的研究,《江苏农学院学报》 19867(8):7-11

  11.崔恒宓#,张牧,章世元,周鹂,马德雨,戴金星,哺乳仔猪补料中添加土霉素试验,《上海畜牧兽医通讯》 1989118-19

  12.崔恒宓#,经荣斌,张牧,张照,香猪生殖器官的发育及血浆雌二醇和睾酮含量变,《中国畜牧杂志》 1989年第25卷第5期:13-16

  13.崔恒宓*,母猪胚胎死亡原因,《国外畜牧科技》 19904月第17卷第2期:18-20

  14.崔恒宓#,经荣斌,许泉法,吴光华,付堂兵,添加柠檬酸对哺乳仔猪影响的初步研究,《畜牧与兽医》1991年第5期(23卷):201-202

  15.张彬,张照,崔恒宓,猪血浆转铁蛋白含量火箭免疫电泳法研究,《湖南农学院学报》 199212月第18卷第4期:986-990

  16.林大光,经荣斌,孙长美,成勇,崔恒宓,李碧春,龚允成,杜淼,邹贤刚,沈三兵,陆德裕,猪的胚胎嵌合试验中若干技术环节的研究,《江苏农学院学报》 199213(1):19-24

  17.张牧,崔恒宓,经荣斌,香猪生长发育规律初探,《上海实验动物科学》 1992121):31-33

  18.崔恒宓#,张照,严忠慎,周建梁,姚连生,姜曲海母猪发情周期性腺激素及其子宫受体含量的变化规律,《畜牧兽医学报》 1992,231):8-12

  19.汪世新,陈天,经荣斌,崔恒宓,毛九德,新型铜饲料添加剂的合成,《江苏农学院学报》 1994年第4:66

  20.徐万祥,石其贤,崔恒宓,大量分离纯净猪卵透明带的一种简便方法,《生殖与避孕》 1994 14 4期:316-317

  21.崔恒宓#,金韶华,毛九德,经荣斌,何良梅,猪脾转移因子的部分生化和免疫性及其应用,《畜牧兽医学报》  1994 25(4)317-322

  22.经荣斌,崔恒宓,汪世新,毛九德,张牧,储新生,尤广凤,氨基酸鳌合铜饲喂生长肥育猪的试验,《江苏农学院学报》 1995 16(3):47-50

  23.张牧,经荣斌,崔恒宓,香猪的生长发育、繁殖特性及其实验动物化研究,《养猪》 19962):30-32

  24.吴一迁,崔恒宓,基因组印记与癌症,《肿瘤》 2002325日第22卷第2期:154-156

  25.吴一迁,崔恒宓,万曙光,金晏,罗海涛,许丽,于永梅,钱耕荪,乙肝病毒对DNA修复基因和肝癌发生的作用,《肿瘤》 2002925日第22卷第5期:379-381

  26.郑明明,胡娅莉,许争峰,王志群,史婷琦,叶晓东,崔恒宓*,实时荧光定量聚合酶链反应技术在产前诊断唐氏综合征中的应用,《中华妇产科杂志》 200410月第39卷第10期:34-37 

  27.胡娅莉,徐运,崔恒宓,王心如,胚胎干细胞的研究进展,《医学研究生学报》2005, 18(1): 77-80

  28.杨薇 ,陈银海 ,崔恒宓*,地西他滨和5_阿扎胞苷在癌症研究及临床上的应用,《中国药学杂志》 200641(21)1601-1605

回国后

  29.刘媛,蒋菁蕊,吴少亘,曹望森,于成功,崔恒宓*miR-483与结直肠癌关系的研究,《胃肠病学》,2014,19 (3): 151-155

  30.蒋菁蕊,刘媛,吴少亘,曹望森,于成功,崔恒宓*miR-483-3p抑制DLC1表达促进结直肠癌发生,《胃肠病学》,2014,19 (7): 394-403

  31.刘洋洋,崔恒宓*DNA甲基化分析中DNA样本重亚硫酸盐处理转化效率的评估方法,《遗传》2015, 37(9):939-944

  32.朱文奇,胡序明,陈世豪,崔恒宓*,禽内源性反转录病毒ALVE表观遗传学分析方法建立及利用,《中国动物传染病学报》201523(5): 15-20

  33.胡序明,朱文奇,陈世豪,崔恒宓*,禽内源性反转录病毒ALVE1 env转录物表达及其调控分析,《中国动物传染病学报》201523(5):27-31

  34.沈丹,谢雨琇,李庆平,薛松磊,史云强,王赛赛,陈才,钱跃,高波,崔恒宓,宋成义,多转座子载体的构建及转座特性比较研究, 《中国农业科学》2015,48(11):2270-2278

  35.朱文奇,胡序明,陈世豪,刘洋洋,孙振,耿拓宇,宋成义,高波,崔恒宓*, miR-155体外特异性靶向鸡内源性反转录病毒ALVE1 env转录物的研究, 《畜牧与兽医》,2016, 48(5): 7-11

  36.田净净,刘洋洋,杨哲,刘菲菲,杨祎擎,韩笑,耿拓宇,高波,宋成义,崔恒宓*,利用CRISPR/Cas9系统高效敲除斑马鱼lncRNA基因启动子区,《中国农业科学》,2016,24(5):649-656

  37.胡序明,崔恒宓*,内源性反转录病毒衍生的长非编码RNA的功能,《生命科学》,2016, 28(6): 695-702

  38.韩笑,胡序明,袁君婷,吕贝,孙振,陈世豪,耿拓宇,崔恒宓*,鸡巨噬细胞HD11不同转染方法的比较分析,《畜牧与兽医》2017, 49(5): 72-76

  39.袁君婷,韩笑,吕贝,胡序明,耿拓宇,崔恒宓*DNA甲基化抑制剂5--2'脱氧胞苷抗癌新机制初探,《肿瘤》2017, 37(3): 201-207

  40.吕贝,李华玲,崔恒宓*,反义RNA与肝癌的研究进展,《安徽医科大学学报》2017, 52(4): 618-621

  41.李华玲,吕贝,袁君婷,韩笑,朱敏,郑丹阳,崔恒宓*, 肝癌相关基因MEF2D反义RNA的鉴定及分析,安徽大学学报,已接受

专利申请:

  1.DNA甲基化分析中DNA样品重亚硫酸盐处理转化率的评估方法,申请号:201610015862.0,申请日:2016.01.11,第一发明人

  2.人源DNA甲基化分析中重亚硫酸盐转化DNA效率的评估方法,申请号:201610017011.X,申请日:2016.01.11,第一发明人

  3.一种终止双等位基因转录的方法,申请号:201610903540X,申请日:2016.10.17,第一发明人

  4.一种终止lncRNA双等位基因转录的方法,申请号:201610905097X,申请日:2016.10.17,第一发明人

  5.一种反义长链非编码RNA在制备基因治疗剂方面的应用,申请号:201710415730.1,申请日:2017.06.02,第二发明人

  6.一种用于肝癌诊断与治疗的反义长链非编码RNA的分析和制备方法,申请号:201710411042.8,申请日:2017.06.02,第一发明人

  7.长链非编码RNA lnc-ALVE1-AS1表达检测引物及试剂盒,申请号:201710883276.2,申请日:2017.09.26,第一发明人

  8.DNA甲基化抑制剂在制备抗J亚群禽白血病病毒增值药物中的应用,申请号:201710884184.6,申请日:2017.09.26,第一发明人

  9.一种抗J亚群禽白血病病毒增值的内源性反转录病毒RNA及其制备方法和应用,申请号:201710881948.6,申请日:2017.09.26,第一发明人

  10.长链非编码RNA lnc-ALVE1-AS1FISH检测探针及试剂盒,申请号:201710884183.1,申请日:2017.09.26,第一发明人

  11.长链非编码RNA lnc-ALVE1-AS1表达Northern blot检测引物、试剂盒,申请号:201710884169.1,申请日:2017.09.26,第一发明人

  12.Aid基因过表达载体质粒的构建方法及应用,申请号:201710928612.0,申请日:2017.10.09,第一发明人

 




打印本页 关闭窗口
© CopyRight 2014 扬州大学动物科学与技术学院 All Rights Reserved.
地址:扬州市文汇东路48号 电话:0514-87972208 传真:0514-87350440 邮箱:dkxy@yzu.edu.cn
Produced By 大汉网络 大汉版通发布系统